Emcure Pharma Set To Launch IPO On July 3
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers for the issue
Bain Capital-backed Emcure Pharmaceuticals will launch its Initial Public Offering (IPO) on July 3, closing on July 5. Bidding for anchor investors will open for a day on July 2, according to the Red Herring Prospectus (RHP).
The IPO consists of a fresh issuance of equity shares worth Rs 800 crore and an Offer for Sale (OFS) of 1.14 crore equity shares by promoters and existing shareholders, including promoter Satish Mehta and Bain Capital affiliate BC Investments IV. Currently, Satish Mehta holds a 41.85 per cent stake in the company, while BC Investments owns 13.07 per cent.
Proceeds from the fresh issue will be used to pay off debt and for general corporate purposes.
Emcure Pharmaceuticals, based in Pune, develops, manufactures, and markets a wide range of pharmaceutical products globally across major therapeutic areas. The company recently received Sebi’s approval to proceed with the IPO.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers for the issue. The equity shares are expected to list on the BSE and NSE on July 10.
(PTI)
